Roger Jeffs is of Axsome Therapeutics, Inc.. Currently has a direct ownership of 120,756 shares of AXSM, which is worth approximately $10.8 Million. The most recent transaction as insider was on Mar 15, 2024, when has been sold 2,347 shares (Common Stock) at a price of $71.61 per share, resulting in proceeds of $168,068. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 121K
0% 3M change
0% 12M change
Total Value Held $10.8 Million

ROGER JEFFS Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 15 2024
SELL
Open market or private sale
$168,068 $71.61 p/Share
2,347 Reduced 1.91%
120,756 Common Stock
Mar 15 2024
BUY
Exercise of conversion of derivative security
$70,198 $29.91 p/Share
2,347 Added 1.87%
123,103 Common Stock
Mar 14 2024
SELL
Open market or private sale
$2,089,327 $69.7 p/Share
29,976 Reduced 19.89%
120,756 Common Stock
Mar 14 2024
BUY
Exercise of conversion of derivative security
$712,829 $23.78 p/Share
29,976 Added 17.87%
137,732 Common Stock
Nov 19 2021
BUY
Open market or private purchase
$147,335 $37.3 p/Share
3,950 Added 3.17%
120,756 Common Stock

Also insider at

LQDA
Liquidia Corp Healthcare
ALBO
ALBIREO PHARMA, INC. Healthcare
RJ

Roger Jeffs

Morrisville, NC

Track Institutional and Insider Activities on AXSM

Follow Axsome Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AXSM shares.

Notify only if

Insider Trading

Get notified when an Axsome Therapeutics, Inc. insider buys or sells AXSM shares.

Notify only if

News

Receive news related to Axsome Therapeutics, Inc.

Track Activities on AXSM